Search Results for: CREB3L1

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
ORMDL1 ORMDL sphingolipid biosynthesis regulator 1
  • Sphingolipid de novo biosynthesis
ORMDL2 ORMDL sphingolipid biosynthesis regulator 2
  • Sphingolipid de novo biosynthesis
PAQR6 progestin and adipoQ receptor family member 6
PEDS1-UBE2V1 PEDS1-UBE2V1 readthrough
  • NOD1/2 Signaling Pathway
  • TICAM1, RIP1-mediated IKK complex recruitment
  • Downstream TCR signaling
  • FCERI mediated NF-kB activation
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • activated TAK1 mediates p38 MAPK activation
  • JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1
  • CLEC7A (Dectin-1) signaling
  • Interleukin-1 signaling
  • IRAK1 recruits IKK complex
  • IKK complex recruitment mediated by RIP1
  • Aggrephagy
  • Aggrephagy
  • TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling
  • IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation
  • Antigen processing: Ubiquitination & Proteasome degradation
PEX16 peroxisomal biogenesis factor 16
  • Class I peroxisomal membrane protein import
  • Class I peroxisomal membrane protein import
  • Zellweger syndrome spectrum, including: Zellweger syndrome (ZS); Adrenoleukodystrophy, neonatal (NALD); Infantile Refsum disease (IRD)
PGAP2 post-GPI attachment to proteins 2
PGRMC1 progesterone receptor membrane component 1
  • Neutrophil degranulation
  • Dextromethorphan
  • Nortriptyline
  • Sertraline
PLN phospholamban
  • Ion homeostasis
  • Ion transport by P-type ATPases
PLP1 proteolipid protein 1
  • Hereditary spastic paraplegia (SPG)
  • Hypomyelinating leukodystrophy (HLD); Pelizaeus-Merzbacher disease (PMD)
PLP2 proteolipid protein 2
PLPP4 phospholipid phosphatase 4
  • Role of phospholipids in phagocytosis
PLPP6 phospholipid phosphatase 6
  • Cholesterol biosynthesis
PLPPR2 phospholipid phosphatase related 2
  • Lysosphingolipid and LPA receptors
PMP22 peripheral myelin protein 22
  • EGR2 and SOX10-mediated initiation of Schwann cell myelination
  • Charcot-Marie-Tooth disease (CMT); Hereditary motor and sensory neuropathy; Peroneal muscular atrophy
PRKAB2 protein kinase AMP-activated non-catalytic subunit beta 2
  • Translocation of SLC2A4 (GLUT4) to the plasma membrane
  • Macroautophagy
  • AMPK inhibits chREBP transcriptional activation activity
  • AMPK inhibits chREBP transcriptional activation activity
  • Carnitine metabolism
  • Activation of PPARGC1A (PGC-1alpha) by phosphorylation
  • Energy dependent regulation of mTOR by LKB1-AMPK
  • TP53 Regulates Metabolic Genes
  • Regulation of TP53 Activity through Phosphorylation
  • Lipophagy
  • Activation of AMPK downstream of NMDARs
  • Adenosine phosphate
  • Acetylsalicylic acid
  • Fostamatinib
PTPN9 protein tyrosine phosphatase non-receptor type 9
  • Interleukin-37 signaling
RFT1 RFT1 homolog
  • Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein
  • Defective RFT1 causes RFT1-CDG (CDG-1n)
  • Congenital disorders of glycosylation (CDG) type I
RHBDD1 rhomboid domain containing 1
RHD Rh blood group D antigen
  • Rhesus blood group biosynthesis
RNASE10 ribonuclease A family member 10 (inactive)

Page 6 out of 10 pages